Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BLOCKING OF TRANSMISSION TO MOSQUITOES BY ANTIBODY TO PLASMODIUM VIVAX MALARIA VACCINE CANDIDATES PVS25 AND PVS28 DESPITE ANTIGENIC POLYMORPHISM IN FIELD ISOLATES

1 Nov 2003

Abstract excerpt

We have previously demonstrated that mouse antisera against yeast-produced recombinant forms of the ookinete surface proteins of Plasmodium vivax (Pvs25 and Pvs28) blocks transmission of the homologous P. vivax (Sal I strain). In this study, we developed mouse and rabbit antisera against Pvs25 and Pvs28 and evaluated the efficacy of these vaccine candidates against natural isolates of P. vivax in Thailand....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Invertebrate Immune Response Mechanisms
Share to Malaria Research and Control
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14695092
DOI: 10.4269/ajtmh.2003.69.536

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BLOCKING OF TRANSMISSION TO MOSQUITOES BY ANTIBODY TO PLASMODIUM VIVAX MALARIA VACCINE CANDIDATES PVS25 AND PVS28 DESPITE ANTIGENIC POLYMORPHISM IN FIELD ISOLATESPMID 14695092Read ↗

Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China.Semantic proximity Read ↗

Evaluation of two Plasmodium vivax sexual-stage antigens as transmission-blocking vaccine candidatesSemantic proximity Read ↗

Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran.Semantic proximity Read ↗

Sequence Polymorphism in Two Novel Plasmodium vivax Ookinete Surface Proteins, Pvs25 and Pvs28, That Are Malaria Transmission-blocking Vaccine CandidatesSemantic proximity Read ↗

Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolatesSemantic proximity Read ↗

Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent.Semantic proximity Read ↗

Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria ParasiteSemantic proximity Read ↗

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge modelsSemantic proximity Read ↗

Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in RodentsSemantic proximity Read ↗

Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoesSemantic proximity Read ↗

Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine CandidatesSemantic proximity Read ↗

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.